Zhang Jiyu from Chengtian Technology: Application of interactive intelligent rehabilitation exoskeleton robots

Recently, at the second Nandu River Forum, Zhang Jiyu, co-founder and vice president of operations of Hangzhou Chengtian Technology, shared the application and industrialization progress of exoskeleton robots in the field of neurological rehabilitation. He emphasized the importance of brain-computer interface in robotics and emphasized that it is the key "connector" between machines and humans.

As people pay more and more attention to health, problems such as stroke and children's health have become increasingly prominent, and a large number of people need rehabilitation. However, traditional rehabilitation methods have the problem of insufficient supply side. This is the opportunity for the intervention of exoskeleton robot technology. Zhang Jiyu believes that exoskeleton robots can not only improve rehabilitation efficiency and reduce limb disability rates, but can also perform functional compensation and even help slow down the aging process.

In this field, Chengtian Technology has achieved remarkable practical results. The exoskeleton robot they developed has been successfully used on 300,000 people, covering more than 20 application scenarios, showing extremely high maturity and broad application prospects. Compared with traditional rehabilitation methods, Cheng Tian's exoskeleton robot has shown higher rehabilitation effects in multiple clinical trials. For example, in the rehabilitation training of stroke patients, after using exoskeleton robots, the patient's knee joint balance has been greatly improved, and the effect is 50% higher than that of traditional methods.

In addition to adult rehabilitation, Chengtian Technology also has special designs for children's rehabilitation. Their products have successfully helped premature children, children with autism, and other children with uncoordinated movements to train themselves to walk, and achieved remarkable results. This year, Chengtian Technology’s products obtained the first domestic exoskeleton robot registration certificate for children, marking the company’s leading position in the field of children’s rehabilitation.

In terms of technology research and development, Chengtian Technology has strong strength. It has accumulated more than 600 intellectual property rights and has the ability to mass produce tens of thousands of exoskeleton robots. This allows their technology to not only stay in the laboratory stage, but actually enter the market. At the same time, Chengtian Technology also actively participates in the formulation of industry standards to promote the healthy development of the entire exoskeleton robot industry.

From helping athletes stand and walk at the Asian Paralympic Games to being widely used in major hospitals and rehabilitation centers, Chengtian Technology's products have been highly recognized by all walks of life. This not only reflects their technical level, but also demonstrates their positive contribution to human health. Looking to the future, they hope that through further technological innovation and market expansion, exoskeleton robotics technology will be valuable in more fields and bring greater convenience and possibility to everyone's life.

Founded in 2017, Chengtian Technology is a national high-tech enterprise with technological innovation as its core driving force. Committed to the development and application of exoskeleton robot technology including core algorithms and core components, it is currently focusing on the fields of rehabilitation and elderly care. By combining human-computer interaction technology, data analysis and cloud computing, it provides medical care institutions and individual users with Intelligent products and solutions. Chengtian Technology's core products include core components and industrial applications, rehabilitation medical care, consumer health care and innovative intelligent applications. Solve rehabilitation problems, mobility problems and self-care problems for disabled people.